178 related articles for article (PubMed ID: 6327286)
1. DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486.
Bourgeois S; Pfahl M; Baulieu EE
EMBO J; 1984 Apr; 3(4):751-5. PubMed ID: 6327286
[TBL] [Abstract][Full Text] [Related]
2. Effects of steroid hormones and antihormones in cultured cells.
Jung-Testas I; Baulieu EE
Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor.
Jung-Testas I; Baulieu EE
Exp Cell Res; 1983 Aug; 147(1):177-82. PubMed ID: 6617759
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of specific transcription and DNA binding studies suggest that in vitro transformed RU 486-glucocorticosteroid receptor complexes display agonist activity.
Schweizer-Groyer G; Cadepond F; Groyer A; Idziorek T; Mariller M; Baulieu EE
J Steroid Biochem; 1988; 30(1-6):291-4. PubMed ID: 3386256
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vivo activation of triamcinolone acetonide- and RU 38486-receptor complexes in the CEM-C7 and IM-9 human leukemic cell lines.
Schmidt TJ
Cancer Res; 1989 Aug; 49(16):4390-5. PubMed ID: 2743328
[TBL] [Abstract][Full Text] [Related]
6. RU 38486: potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation.
Moguilewsky M; Philibert D
J Steroid Biochem; 1984 Jan; 20(1):271-6. PubMed ID: 6708512
[TBL] [Abstract][Full Text] [Related]
7. Binding of the anti-progestin RU-486 to rat ovary steroid receptors.
Schreiber JR; Hsueh AJ; Baulieu EE
Contraception; 1983 Jul; 28(1):77-85. PubMed ID: 6627946
[TBL] [Abstract][Full Text] [Related]
8. Chick oviduct glucocorticosteroid receptor. Specific binding of the synthetic steroid RU 486 and immunological studies with antibodies to chick oviduct progesterone receptor.
Groyer A; Le Bouc Y; Joab I; Radanyi C; Renoir JM; Robel P; Baulieu EE
Eur J Biochem; 1985 Jun; 149(2):445-51. PubMed ID: 3996417
[TBL] [Abstract][Full Text] [Related]
9. In vitro activation and DNA binding affinity of human lymphoid (CEM-C7) cytoplasmic receptors labeled with the antiglucocorticoid RU 38486.
Schmidt TJ
J Steroid Biochem; 1986 Apr; 24(4):853-63. PubMed ID: 2871233
[TBL] [Abstract][Full Text] [Related]
10. Physical characterization of the activated and non-activated forms of the glucocorticoid-receptor complex bound to the steroid antagonist [3H]RU 486.
Sablonniere B; Danze PM; Formstecher P; Lefebvre P; Dautrevaux M
J Steroid Biochem; 1986 Nov; 25(5A):605-14. PubMed ID: 3795940
[TBL] [Abstract][Full Text] [Related]
11. Specific binding of the glucocorticoid-receptor complex to the mouse mammary tumor proviral promoter region.
Pfahl M
Cell; 1982 Dec; 31(2 Pt 1):475-82. PubMed ID: 6297768
[TBL] [Abstract][Full Text] [Related]
12. Purified glucocorticoid receptor-hormone complex from rat liver cytosol binds specifically to cloned mouse mammary tumor virus long terminal repeats in vitro.
Govindan MV; Spiess E; Majors J
Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5157-61. PubMed ID: 6291027
[TBL] [Abstract][Full Text] [Related]
13. Autoradiographic localization of glucocorticosteroid and progesterone binding sites in the human post-mortem brain.
Sarrieau A; Dussaillant M; Agid F; Philibert D; Agid Y; Rostene W
J Steroid Biochem; 1986 Nov; 25(5B):717-21. PubMed ID: 3807360
[TBL] [Abstract][Full Text] [Related]
14. Spironolactone, an aldosterone antagonist, acts as an antiglucocorticosteroid on the mouse mammary tumor virus promoter.
Couette B; Marsaud V; Baulieu EE; Richard-Foy H; Rafestin-Oblin ME
Endocrinology; 1992 Jan; 130(1):430-6. PubMed ID: 1309341
[TBL] [Abstract][Full Text] [Related]
15. RU 38486: a potent antiglucocorticoid in vitro and in vivo.
Gagne D; Pons M; Philibert D
J Steroid Biochem; 1985 Sep; 23(3):247-51. PubMed ID: 2864478
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid receptors bound to the antagonist RU486 are not downregulated despite their capacity to interact in vitro with defined gene regions.
Rajpert EJ; Lemaigre FP; Eliard PH; Place M; Lafontaine DA; Economidis IV; Belayew A; Martial JA; Rousseau GG
J Steroid Biochem; 1987 May; 26(5):513-20. PubMed ID: 3035286
[TBL] [Abstract][Full Text] [Related]
17. Correlation of glucocorticoid receptor binding sites on MMTV proviral DNA with hormone inducible transcription.
Pfahl M; McGinnis D; Hendricks M; Groner B; Hynes NE
Science; 1983 Dec; 222(4630):1341-3. PubMed ID: 6318311
[TBL] [Abstract][Full Text] [Related]
18. Covalent and noncovalent receptor-glucocorticoid complexes preferentially bind to the same regions of the long terminal repeat of murine mammary tumor virus proviral DNA.
Miller PA; Ostrowski MC; Hager GL; Simons SS
Biochemistry; 1984 Dec; 23(26):6883-9. PubMed ID: 6099146
[TBL] [Abstract][Full Text] [Related]
19. RU 486 stabilizes a high molecular weight form of the glucocorticoid receptor containing the 90K non-steroid binding protein in intact thymus cells.
Lefebvre P; Formstecher P; Richard C; Dautrevaux M
Biochem Biophys Res Commun; 1988 Feb; 150(3):1221-9. PubMed ID: 3342067
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of in vitro immunosuppressive effects of glucocorticosteroids by a competitive antagonist RU-486.
Emilie D; Galanaud P; Baulieu EE; Dormont J
Immunol Lett; 1984; 8(4):183-6. PubMed ID: 6238907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
